UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 449

Sortiert nach

Dysfunctional HDL and atherosclerotic cardiovascular disease

Nature reviews cardiology, 2016-01, Vol.13 (1), p.48

2016

Link zum Volltext

Verfügbarkeit prüfen

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Clinical chemistry (Baltimore, Md.), 2011-03, Vol.57 (3), p.392-410

2011

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Circulation (New York, N.Y.), 2012-04, Vol.125 (15), p.1905-1919

2012

Link zum Volltext

Verfügbarkeit prüfen

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Circulation (New York, N.Y.), 2004-07, Vol.110 (2), p.227-239

2004

Link zum Volltext

Verfügbarkeit prüfen

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

The New England journal of medicine, 2017-05, Vol.376 (20), p.1933-1942

2017

Link zum Volltext

Verfügbarkeit prüfen

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Journal of the American College of Cardiology, 2004-08, Vol.44 (3), p.720-732

2004

Link zum Volltext

Verfügbarkeit prüfen

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

European heart journal, 2016-02, Vol.37 (6), p.536-545

2016

Link zum Volltext

Verfügbarkeit prüfen

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition

Circulation (New York, N.Y.), 2004-01, Vol.109 (3), p.433-438

2004

Link zum Volltext

Verfügbarkeit prüfen

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

Nature reviews cardiology, 2018-01, Vol.15 (1), p.9

2018

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

The Lancet (British edition), 2015-08, Vol.386 (9992), p.452-460

2015

Link zum Volltext

Verfügbarkeit prüfen

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

The Journal of biological chemistry, 2003-01, Vol.278 (4), p.2563-2570

2003

Link zum Volltext

Verfügbarkeit prüfen

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2727-2735

2010

Link zum Volltext

Verfügbarkeit prüfen

Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

Circulation (New York, N.Y.), 2013-09, Vol.128 (11), p.1256-1267

2013

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Journal of the American College of Cardiology, 2015-11, Vol.66 (20), p.2201-2210

2015

Link zum Volltext

Verfügbarkeit prüfen

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2004-03, Vol.24 (3), p.387

Brewer, Jr, H Bryan

2004

Link zum Volltext

Verfügbarkeit prüfen

Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome

Circulation research, 2014-06, Vol.114 (12), p.1880-1889

2014

Link zum Volltext

Verfügbarkeit prüfen

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Arteriosclerosis, thrombosis, and vascular biology, 2004-02, Vol.24 (2), p.e13

2004

Link zum Volltext

Verfügbarkeit prüfen

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2003-02, Vol.23 (2), p.160

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of Torcetrapib in Patients at High Risk for Coronary Events

The New England journal of medicine, 2007-11, Vol.357 (21), p.2109-2122

2007

Link zum Volltext

Verfügbarkeit prüfen

human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver

Journal of lipid research, 2005-10, Vol.46 (10), p.2151-2167

2005

Link zum Volltext

Verfügbarkeit prüfen

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Arteriosclerosis, thrombosis, and vascular biology, 2004-08, Vol.24 (8), p.e149

2004

Link zum Volltext

Verfügbarkeit prüfen

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2004-10, Vol.24 (10), p.1755

2004

Link zum Volltext

Verfügbarkeit prüfen

Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity

The Journal of biological chemistry, 2003-11, Vol.278 (46), p.45062-45071

2003

Link zum Volltext

Verfügbarkeit prüfen

Increasing HDL Cholesterol Levels

The New England journal of medicine, 2004-04, Vol.350 (15), p.1491-1494

Brewer, H. Bryan

2004

Link zum Volltext

Verfügbarkeit prüfen

benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

The American journal of cardiology, 2003-08, Vol.92 (4), p.23-29

Brewer, H.Bryan

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 449

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(410)
Mit Volltextzugriff
(384)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(448)
Japanisch
(86)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Dysfunctional HDL and atherosclerotic cardiovascular disease

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

Lipoproteins as Biomarkers and Therapeutic Targets in the Setting of Acute Coronary Syndrome

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

Effects of Torcetrapib in Patients at High Risk for Coronary Events

human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease

Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity

Increasing HDL Cholesterol Levels

benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

Suchergebnisse filtern